These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34507401)

  • 1. Glioblastoma with Primitive Neuroectodermal Component Treated with Adjuvant Radiotherapy and Temozolomide: A Pooled Analysis of 23 Patients.
    Benson R; Mallick S; Purkait S; Haresh KP; Gupta S; Sharma MC; Suri V; Sharma D; Rath GK
    Neurol India; 2021; 69(4):856-860. PubMed ID: 34507401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Individual Patient Data Analysis of Uncommon Variants of Glioblastoma: An Analysis of 196 Cases.
    Mallick S; Benson R; Venkatesulu B; Melgandi W; Rath GK
    Neurol India; 2022; 70(5):2086-2092. PubMed ID: 36352613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component.
    O'Leary B; Mandeville HC; Fersht N; Solda F; Mycroft J; Zacharoulis S; Vaidya S; Saran F
    J Neurooncol; 2016 Apr; 127(2):295-302. PubMed ID: 26842817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: Case report and review of the literature.
    Prelaj A; Rebuzzi SE; Caffarena G; Giròn Berrìos JR; Pecorari S; Fusto C; Caporlingua A; Caporlingua F; Di Palma A; Magliocca FM; Salvati M; Tomao S; Bianco V
    Oncol Lett; 2018 May; 15(5):6641-6647. PubMed ID: 29616127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
    Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
    J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
    Gerber NU; von Hoff K; Resch A; Ottensmeier H; Kwiecien R; Faldum A; Matuschek C; Hornung D; Bremer M; Benesch M; Pietsch T; Warmuth-Metz M; Kuehl J; Rutkowski S; Kortmann RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):863-71. PubMed ID: 24969797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's in a name? Intracranial peripheral primitive neuroectodermal tumors and CNS primitive neuroectodermal tumors are not the same.
    Müller K; Diez B; Muggeri A; Pietsch T; Friedrich C; Rutkowski S; von Hoff K; von Bueren AO; Zwiener I; Bruns F
    Strahlenther Onkol; 2013 May; 189(5):372-9. PubMed ID: 23519360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A primitive neuroectodermal tumor in an adult: Case report of a unique location and MRI characteristics.
    He X; Chen Z; Dong Y; Tong D
    Medicine (Baltimore); 2018 Feb; 97(7):e9933. PubMed ID: 29443778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice.
    Carter TC; Medina-Flores R; Lawler BE
    Biomed Res Int; 2018; 2018():6204676. PubMed ID: 30687753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
    Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early dural metastasis from a case of glioblastoma with primitive neuroectodermal differentiation: A case report and literature review.
    Konar SK; Bir SC; Maiti TK; Patra DP; DiPoto Brahmbhatt AC; Jacobsohn JA; Nanda A
    J Clin Neurosci; 2017 Jan; 35():78-81. PubMed ID: 28029420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
    J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients.
    Okumus NO; Gursel B; Meydan D; Ozdemir O; Odabas E; Gonullu G
    Ann Saudi Med; 2012; 32(3):250-5. PubMed ID: 22588435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.
    Cao JQ; Fisher BJ; Bauman GS; Megyesi JF; Watling CJ; Macdonald DR
    J Neurooncol; 2012 Apr; 107(2):395-405. PubMed ID: 22105851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent diffusion coefficient in glioblastoma with PNET-like components, a GBM variant.
    Ali S; Joseph NM; Perry A; Barajas RF; Cha S
    J Neurooncol; 2014 Sep; 119(2):353-60. PubMed ID: 24893732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.